Insider Transactions in Q1 2025 at Mersana Therapeutics, Inc. (MRSN)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 16
2025
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
8,048
-3.03%
|
$0
$0.58 P/Share
|
|
Jan 16
2025
|
Anna Protopapas Director |
SELL
Open market or private sale
|
Direct |
8,637
-4.89%
|
$0
$0.58 P/Share
|
|
Jan 16
2025
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,554
-5.82%
|
$0
$0.58 P/Share
|
|
Jan 16
2025
|
Brian De Schuytner SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
8,470
-6.52%
|
$0
$0.58 P/Share
|
|
Jan 16
2025
|
Martin H. Huber Jr. President, CEO |
SELL
Open market or private sale
|
Direct |
4,514
-3.54%
|
$0
$0.58 P/Share
|
|
Jan 16
2025
|
Mohan Bala SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,939
-7.94%
|
$0
$0.58 P/Share
|
|
Jan 16
2025
|
Alejandra Carvajal SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,096
-6.11%
|
$0
$0.58 P/Share
|
|
Jan 15
2025
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,791
+3.65%
|
-
|
|
Jan 15
2025
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+10.74%
|
-
|
|
Jan 15
2025
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,685
+6.87%
|
-
|
|
Jan 15
2025
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,833
+7.62%
|
-
|
|
Jan 15
2025
|
Martin H. Huber Jr. President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,062
+7.99%
|
-
|
|
Jan 15
2025
|
Mohan Bala SVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,583
+16.31%
|
-
|
|
Jan 15
2025
|
Alejandra Carvajal SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+13.04%
|
-
|
|
Jan 15
2025
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,791
-3.31%
|
$0
$0.63 P/Share
|
|
Jan 15
2025
|
Anna Protopapas Director |
SELL
Open market or private sale
|
Direct |
6,191
-3.83%
|
$0
$0.63 P/Share
|
|
Jan 15
2025
|
Alejandra Carvajal SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
952
-1.33%
|
$0
$0.63 P/Share
|
|
Jan 15
2025
|
Brian De Schuytner SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
2,331
-2.09%
|
$0
$0.63 P/Share
|
|
Jan 15
2025
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
1,794
-0.72%
|
$0
$0.63 P/Share
|
|
Jan 14
2025
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,783
+8.11%
|
-
|
|
Jan 14
2025
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,750
+9.39%
|
-
|
|
Jan 14
2025
|
Alejandra Carvajal SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+3.36%
|
-
|
|
Jan 14
2025
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+5.31%
|
-
|
|
Jan 14
2025
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,792
+1.9%
|
-
|
|
Jan 14
2025
|
Anna Protopapas Director |
SELL
Open market or private sale
|
Direct |
11,534
-7.37%
|
$0
$0.66 P/Share
|
|
Jan 14
2025
|
Mohan Bala SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,253
-5.12%
|
$0
$0.66 P/Share
|
|
Jan 14
2025
|
Alejandra Carvajal SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,330
-4.58%
|
$0
$0.66 P/Share
|
|
Jan 14
2025
|
Brian De Schuytner SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
3,713
-3.41%
|
$0
$0.66 P/Share
|
|
Jan 14
2025
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
3,483
-1.41%
|
$0
$0.66 P/Share
|
|
Jan 14
2025
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,007
-2.0%
|
$0
$0.66 P/Share
|
|
Jan 13
2025
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+16.65%
|
-
|
|
Jan 13
2025
|
Mohan Bala SVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+12.11%
|
-
|
|
Jan 13
2025
|
Alejandra Carvajal SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,958
+10.97%
|
-
|
|
Jan 13
2025
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.42%
|
-
|
|
Jan 13
2025
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+3.67%
|
-
|
|
Jan 13
2025
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,646
+4.99%
|
-
|